Major changes in psychiatric phenotypes due to genetic factors are seldom the result of single gene polymorphisms, but more often the result of several genetic mechanisms. In this millennium article we discuss the notion that the expression of numerous candidate genes could be regulated by the same transcription factors, and that polymorphisms in transcription factor genes might explain some phenotypes. We describe recent results of studies on the biological marker thrombocyte monoamine oxidase (trbc MAO) and the transcription factor AP-2␤. Low levels of trbc MAO is associated with temperamental characteristics such as sensation seeking and impulsiveness, and the enzyme is genetically regulated by specific transcriptional mechanisms. Transcription factor AP-2␤ is important for the development of midbrain structures and AP-2␤ has several binding sites in the regulatory regions of genes encoding key proteins in the monoamine transmitter systems. We have recently shown AP-2␤ to be linked to personality, binge-eating disorder, treatment with antidepressant drugs, and also to trbc MAO. Regardless of whether transcriptions factors, such as AP-2␤, regulate the expression of eg, the number of monoamine neurons or a variety of candidate genes within the monoamine systems, or both, we would like to emphasize the role of transcription factors, besides polymorphisms in monoaminergic candidate genes, when explaining inter-individual differences in temperament and psychiatric vulnerability. Molecular Psychiatry (2001) 6, 503-510.
Introduction
Over the last decades there has been an increasing optimism about applying molecular genetics to human behavior and disease. A large amount of articles have been published showing associations of specific gene alleles to certain psychiatric syndromes and many investigations on candidate genes are still carried out. In some cases they have yielded interesting results, but quite often the results have been difficult to reproduce, probably because the effect of a single gene polymorphism rarely results in a great change in the phenotype. During the last years researchers have started to focus on identifying combinations of genes that are all linked to one disease or syndrome, an approach which seems to have been successful in some cases (for a recent review, see Comings 1 ). The possibilities of future exploration of the notion that a combination of genes is involved in expressing specific psychiatric phenotypes have recently been thoroughly discussed in a paper in this journal. 2 In the present article we would like to extend this notion with the suggestion that the expression of several of these genes is regulated by the same transcription factors, and, that in this way, polymorphisms in transcription factor genes might explain some phenotypes not showing up as associated with specific variants of the likely candidate genes. Cornerstones in this hypothesis are recent results of studies on the biological marker thrombocyte monoamine oxidase (trbc MAO)(E.C.1.4.3.4) and the transcription factor AP-2␤.
Thrombocyte monoamine oxidase as a biological marker
Monoamine oxidases of type A and B are flavine-containing enzymes which oxidatively deaminate the neurotransmitters dopamine, noradrenaline, and serotonin as well as exogenous monoamines. Trbc MAO is of the B-type and has the same amino acid sequence as brain MAO-B. 3 The enzyme activity is stable during lifetime, however with a possible minor increase after the age of 40. [4] [5] [6] Several family and twin studies have shown a high degree of heritability, and in the study of Pedersen et al 7 a heritability factor of about 0.75 was found for both males and females. Low trbc MAO has, in clinical studies, been shown to correlate with personality characteristics such as sensation seeking, impulsiveness and monotony avoidance. 8, 9 In studies on non-human primates, associations between trbc MAO and behavior were reported, which, in essence, confirmed the findings in humans. 10 Those early studies on rhesus monkeys have recently been nicely confirmed and considerably extended. 11 Other support for a connection between the enzyme and CNS function stems from the report by Sostek et al 12 that trbc MAO activity is related to the behavior in new-born babies such as screaming and motor activity as well as their consolability. Also investigations on the correlation between trbc MAO activity and neuropsychological measures support the notion of trbc MAO as a stable biological marker, where the simplest way to describe the results is to say that low MAO probands prefer speed before accuracy. 13 It is crucial to notice that drug-induced inhibition of trbc MAO does not result in major alterations in temperament and knock-out mice deficient in MAO-B do not display changed behavior.
14 Altered levels of trbc MAO have been associated with a number of psychiatric conditions. 15 The finding that components in cigarette smoke have inhibitory properties on MAO-B both in brain 16 and in platelets 17 has cast some doubt on the validity of the findings about the associations between personality and trbc MAO. Thus, as has recently been reviewed, 18 personality traits predisposing for smoking behavior are essentially the same as those associated with low trbc MAO. Since those personality traits are also predisposing for alcohol abuse, it has been suggested that low trbc MAO should not at all be associated with eg alcoholism 19 and thereby, indirectly, not with personality, ie that all of the findings should be an effect of smoking. However, besides a variety of clinical data reviewed by Oreland et al, 18 recent data from studies on non-human (non-smoking) primates have, again, excellently confirmed those associations, including an enhanced predisposition for voluntary alcohol intake in low trbc MAO probands.
11
There are several theoretical possibilities to explain the association between trbc MAO activity and personality/behavior, some of which recently have been explored. 20 For reasons given in that review, we consider the most probable hypothesis being that trbc MAO can be considered a genetic marker, which is regulated by mechanisms also regulating some brain function(s) of importance for personality. Thus, in healthy individuals there is a significant correlation between cerebrospinal fluid levels of the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA) and trbc MAO activity. 21 This is in good agreement with the finding that both adult men with a tendency for aggressive behavior and aggressive children and youths have low concentrations of 5-HIAA in the cerebral spinal fluid. 22, 23 Such individuals are also likely to have low activity of trbc MAO. 24 Low levels of CSF 5-HIAA have also been linked to type 2 alcoholism, 25 whose subjects in several studies have also been found to have low trbc MAO activity. 26 
Transcriptional regulation of trbc MAO
A few studies on structural differences of the MAOB gene in relation to specific enzymatic activity have been performed. However, these studies demonstrate that these differences seem to be of minor importance. 27, 28 Most likely a large portion of the regulation of MAO-B activity is governed at a transcriptional level, this process being controlled by several transcription factors. 29 These DNA binding proteins interact with specific sequences of untranslated regulatory regions, thereby enhancing or inhibiting gene transcription and subsequent protein expression. This notion is supported by results showing that the expression of MAOB mRNA in various tissues seems to correlate with the regional distribution of the catalytic activity of the enzyme. 30 The specific characteristics of the human MAOB gene promoter have been described and several fragments have been investigated with reporter gene assays. 29, 31 For example, the maximal promoter activity for MAOB has been observed for a 0.15-kb GC-rich sequence close to the first exon of the gene. 29 Since no nuclear material is conferred to the platelets when they are released from the megakaryocytes, direct analysis of transcriptional regulation of MAO-B in platelets is not possible. However, we have previously reported that there is a high correlation between white blood cell MAO-B activity and trbc MAO activity (r = 0.98; n = 20). 32 Therefore, we used nuclear extracts from human white blood cells to perform gel-shift analyses of the occurrence of proteins that bind to the 0.15-kb sequence of the MAOB promoter. Samples were obtained from male, non-smoking volunteers selected for a wide spread of trbc MAO activity. After incubation of the radiolabelled 0.15-kb fragment with the nuclear extracts, three bands were observed. One of these bands corresponded to the Sp1 transcription factor. No association was found between any individual transcription factor and trbc MAO activity. This was not unexpected since the loading of nuclear extracts is difficult to standardize. However, when the ratio between the two 'non-Sp1' bands was plotted against trbc MAO activity, a strong correlation was observed (r = 0.96; P = 0.002). 33 These data strongly suggest that these two yet uncharacterized transcription factors are of major importance for the transcriptional regulation of MAO-B in blood cells.
Transcription factor family AP-2
Transcription factor AP-2 is a family of different, yet closely related, proteins that are expressed from different genes. Three different isoforms of AP-2, ie, AP-2␣, AP-2␤, and AP-2␥ have been identified. [34] [35] [36] [37] [38] The proteins have been reported to have very similar biochemical properties and the palindromic sequence 5Ј-GCCNNNGGC-3Ј is considered as consensus binding sites for all three AP-2 isoforms. 39, 40 The function of AP-2 is increased by two different signal-transduction pathways. AP-2 seems to mediate transcriptional acti-vation in response to both the phorbol-ester-and diacylglycerol-activated protein kinase C, and the cAMP-dependent protein kinase A. 41, 42 In the mammalian central nervous system, the transcription factor AP-2 is one of the critical regulatory factors for neural gene expression and neural development. Thus, the AP-2 factors are essentially expressed in most brain regions during both development and in the mature brain. There is an overlapping distribution of the two most abundant isoforms, ie AP-2␣ and AP-2␤ in the mature mouse brain. However, the expression of AP-2␤ is higher than that of AP-2␣ in many regions. Regions where AP-2␤ seems to be more abundant are eg, hippocampus, midbrain, and cerebral cortex. 43 The gene encoding AP-2␤ is located on chromosome 6p12-p21.1 and includes a polymorphic region consisting of a variable number of [CAAA] repeats located in the second intron between nucleotides 12593 and 12612, close to the 3Ј-splice site of exon 2. The [CAAA] sequence is repeated either four or five times. 44 The functional importance of this variable region has not yet been elucidated.
Since several of the dopaminergic and serotonergic genes involved in the midbrain CNS transmitter systems have AP-2 binding sites in their regulatory regions, [45] [46] [47] [48] [49] [50] [51] [52] [53] one may speculate that the expression and activity of different isoforms of AP-2 influence mood and personality, not only due to their role during development of the brain, but also due to their function during adulthood. In order to investigate AP-2␤ as a novel candidate gene in psychiatric disorders and personality we have previously published significant associations with several personality traits, 54 and levels of trbc MAO. 55 Recently, we identified AP-2␤ as a novel candidate gene in females with binge-eating disorder. Moreover, we have also identified AP-2␤ as a downstream molecular target for drugs used in the treatment for affective disorders. 56 Previous publications and novel data on binge-eating disorder will be discussed below.
Transcription factor AP-2␤ and personality
Since the midbrain contains structures important for variables as mood and personality, we investigated if the genotype of AP-2␤ was associated with personality as estimated by the Karolinska Scales of Personality (KSP). 54 The KSP include 15 sub-scales which have been shown to partly correlate with the TPQ and EPQ, eg, TPQ-harm avoidance sub-scales vs KSP anxietyrelated scales. 57 Moreover, neuroticism-related KSP sub-scales are highly correlated with the neuroticism sub-scales in NEO-PI-R. 58 AP-2␤ genotype and KSP scores were determined for 137 Caucasian volunteers (73 females and 64 males). The outcome of this study showed that several personality traits were significantly associated with AP-2␤ genotype. The observed frequencies of genotypes in our sample were [CAAA] 5 13 .9%. In the present sample, simple regression analyses did not reveal any significant correMolecular Psychiatry lation between age or gender of the subjects and any of the personality traits that were estimated by the KSP. Moreover, chi-square analysis did not reveal any significant correlation between gender and specific AP-2␤ genotype. The personality traits muscular tension, guilt, somatic anxiety, psychastenia, and indirect aggression were significantly associated with homozygosity for the long [CAAA] 5 allele. Despite the fact that gender was not significantly correlated to any of the personality traits found to be associated with the AP-2␤ genotype, opposite results were obtained between females and males on the association between indirect aggression and homozygosity for the long allele. In 1993, a gender difference with opposite scores for indirect aggression between males and females with regard to trbc MAO activity was reported by Helleday et al. 59 This gender difference for indirect aggression is in line with our findings. Females homozygous for the long allele displayed lower scores for anxiety-related personality traits and indirect aggression. In contrast, males homozygous for the long allele displayed a higher score for indirect aggression. In conclusion, the associations between KSP personality traits and the AP-2␤ polymorphism suggest that AP-2␤ influences functions in the central nervous system. We speculate that these events take place especially during development of the midbrain neurotransmitter systems and therefore give rise to specific personality characteristics in the adult.
Transcription factor AP-2␤ and binge-eating disorder
It has been suggested that binge-eating disorder, characterized by recurrent episodes of binge eating in the absence of the regular use of inappropriate compensatory behaviors characteristic of bulimia nervosa, is associated with impaired impulsive control. 60 Strong research evidence have been published of impulse control disorders involving a serotonergic component (for reviews, see Linnoila et al, 61 Lesch and Merschdorf 62 ). In this study, subjects with eating disorders were recruited by advertisements in the Swedish magazine Amelia where women with binge-eating episodes were asked to participate in the study. In this way 46 women meeting the DSM-IV, Appendix B, criteria for eating disorder, NOS (binge-eating disorder) with a mean body mass index of 30.49 (SD 5.78) and a mean body weight of 83.95 kg (SD 16.60) were recruited for participation in the investigation. A psychiatrist interviewed all individuals, and subjects with other psychiatric or personality disorders were excluded. Control subjects were 73 healthy female volunteers with a mean body mass index of 24.4 (SD 4.0) and a mean body weight of 67.6 kg (SD 11.6). The control individuals were all living in the catchment area of the Karolinska hospital in Stockholm and randomly selected from the population register. Of 184 individuals who volunteered to participate in a previous psychiatric interview study, 137 (64 men and 73 women) also consented to deliver blood samples for determination of genetic markers, and the samples from the 73 women were used in the present study. After complete description of the study to the subjects, written informed consent was obtained.
Blood samples of approximately 7 ml were drawn from the subjects and 1 ml of whole blood was frozen at −20°C for later genetic analysis. Genomic DNA was prepared from this sample by use of a Qiamp DNA extraction kit (Qiagen, CA, USA) and the DNA was stored at −20°C. PCR reactions with subsequent estimations of allelic genotypes, and radiometric assay of catalytic trbc MAO activity with 14 C-␤-phenylethylamine as substrate were carried out as previously described. 54, 63 Intron 2 genotypes for AP-2␤, KSP scores and trbc MAO activity were determined for all individuals. In the binge-eating patients, four patients (9%) were homozygous for the short AP-2␤ intron 2 allele, 13 patients (28%) were heterozygous, and 29 patients (63%) were homozygous for the long allele. In the control individuals, 13 (18%) were homozygous for the short allele, 34 (46%) were heterozygous, and 26 (36%) were homozygous for the long allele. The observed genotype frequencies in the control group were in accordance with previously published results. 54 When genotype frequencies were compared between the two groups, a statistically significant difference was observed with a higher frequency (63%) of homozygots for the long allele in the patients with binge-eating disorder than in controls (36%); ( 2 = 7.47, P Ͻ 0.0063; see Table 1 ).
When trbc MAO was analyzed, 14 smoking patients were excluded due to the inhibitory influence of tobacco smoke on the enzyme activity (see above). None of the control individuals were smokers. The catalytic activities of trbc MAO were not significantly different between the group of binge-eating patients and the control group. The group of binge-eating patients showed a mean (SD) trbc MAO activity of 14.5 ± 4.2 nmol 10 10 platelets −1 min −1 , and the individuals of the control group displayed a mean trbc MAO activity of 14.1 ± 3.2 (F = 0.01; P = 0.91).
Interestingly, when the binge-eating patients were sub-divided according to their AP-2␤ genotype, the patients homozygous for the long allele displayed significantly lower trbc MAO activity compared to the sub-group of patients with either two short alleles or , and trbc MAO activity in the patients heterozygous or homozygous for the short allele was 16.3 ± 5.4 (F = 5.5; P = 0.026).
Since low trbc MAO activity as well as intron 2 genotype of AP-2␤ have separately been associated with specific personality traits as estimated by the KSP, we also performed analyses of the expression of personality traits in relation to the AP-2␤ genotype on the patients with binge-eating disorder. Of the 46 patients, 31 completed the KSP questionnaire and were included in this investigation of personality traits. The patients with two long AP-2␤ alleles (n = 18) showed significantly higher scores on the KSP sub-scale for impulsiveness compared to the patients with one or two short alleles (n = 13), 60.0 ± 11.1 and 51.2 ± 12.1 respectively (F = 4.4; P = 0.045). Moreover, patients with two long alleles displayed higher scores on the KSP sub-scale for monotony avoidance than did patients with one or two short alleles, 62.1 ± 10.9 and 56.2 ± 7.1 respectively. However, the difference in monotony avoidance between the two groups did not reach a statistically significant level (F = 2.9; P = 0.10) ( Table 2) .
Our interpretation of the results is that they indicate that the long allele, ie [CAAA] 5 , of the human AP-2␤ gene is implicated in binge-eating disorder, and that the results also support previous data on a connection between AP-2␤ intron 2 genotype and catalytic activity of trbc MAO.
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AP-2 and drugs used in the treatment of affective disorders
Several of the genes in the serotonergic and the dopaminergic systems have consensus binding sites for the AP-2 transcription factor family in their regulatory regions. Imbalances in these systems have been implicated in many psychiatric disorders, including depression and bipolar affective disorder. Recently, we demonstrated that chronic administration of three different classes of antidepressant drugs modulates the level and DNA-binding activity of AP-2 in the rat brain. Chronic administration of citalopram (10 mg kg Recently, numerous studies have shown that antidepressant drugs have an effect on the mRNA levels of several monoaminergic genes. Interestingly, genes with multiple binding sites for AP-2 have been shown to be affected by antidepressant drug treatment. Thus, it has been reported that the transcriptional activity of the dopamine D2 receptor is decreased in vitro by citalopram and imipramin. 64 The mRNA levels of the dopamine transporter are decreased after treatment with imipramin in transgenic mice underexpressing glucocorticoid receptors. 65 Furthermore, the mRNA levels of the dopamine D1 receptor are decreased after treatment with imipramine and fluoxetine. 66 The serotonin transporter has been investigated with regard to clinical response to antidepressant drugs. Patients with a specific genotype of 5-HTT (producing high expression of 5-HTT) respond better to treatment with antidepressants than patients with a 5-HTT genotype connected to low expression of 5-HTT. 67 Since we observe effects from antidepressant drug treatment on AP-2, which has the ability to regulate these genes, we speculate that the downstream effect of antidepressants on AP-2 will give rise to adaptations and alterations regarding expression of AP-2 target genes. Thus, subsequent changes in specific expression levels of monoaminergic genes might be dependent on the antidepressant effect of a number of transcription factors, including AP-2.
It has for a long time been suggested that small molecules may interfere with gene transcription. However, in what manner this is accomplished is still largely unknown. It is very likely that regulation of gene tran- *The group of patients homozygous for the long allele displayed a significantly higher score on the KSP scale for impulsiveness (F = 4.4; P = 0.045).
Molecular Psychiatry scription will be an important target for the action of future pharmaceuticals. 68 Numerous recent articles are optimistic, considering it probable that the 'transcription-based approach' will yield a valuable contribution, and that this approach will lead to the development of a new generation of specific and effective pharmaceutical agents that can modulate human metabolism with a high degree of precision. [69] [70] [71] An increased understanding of the function of transcription factors and their involvement in vulnerability for psychiatric disease, could in the future make it possible to identify compounds that exert their therapeutic action at the transcriptional level. Surely, many human transcription factors have not yet been characterized, and some of these proteins may prove to be novel and ideal drug targets.
Transcription factor AP-2␤ and trbc MAO
With regard to the previously described association between trbc MAO and certain personality characteristics, it has been proposed that common developmental mechanisms may regulate the enzyme expression as well as other proteins involved in complex CNS functions. 72 The association of both trbc MAO and the genotype of AP-2␤ with personality characteristics might suggest that these two markers in some way are linked to each other. Moreover, since the regulatory regions of the MAOB gene as well as several other genes of the central monoaminergic systems contain potential binding sites for AP-2, 73 we have tested the hypothesis that transcription factor AP-2␤ is connected to the expression of the human MAOB gene in megakaryocytes as estimated by trbc MAO activity. 55 Male (n = 158) and female subjects (n = 64) were analyzed with regard to AP-2␤ intron 2 genotype and trbc MAO activity. When analyzing the male individuals we observed that those homozygous for the long allele displayed significantly lower trbc MAO activity as compared to those with one or two short alleles (F = 18.054, P Ͻ 0.0001; see Figure 1 ). Similarly, women homozygous for the long allele had lower trbc MAO activity than those with one or two short alleles (F = 6.163, P = 0.0158; see Figure 1 ).
The functional relevance of the AP-2␤ intron 2 polymorphism is currently being investigated. It may be in linkage disequilibrium with a reported dimorphism located in the 5Ј regulatory region upstream of the AP-2␤ gene. The variable intron 2 region may also directly have a regulatory influence on the gene. Nevertheless, based on the present data we suggest that the intron 2 genotype of AP-2␤ is of relevance for the regulation of trbc MAO protein expression.
General summary and conclusions
According to our working hypothesis, transcription factors such as AP-2␤ could, besides playing a role for the expression of some components of the CNS, possibly within the monoamine systems, also have an impact on the expression of trbc MAO. AP-2␤ is known to be important for the embryonic development of the mammalian midbrain structures, 74, 75 and has recently, as described above, been shown to be linked to personality, binge-eating disorder, trbc MAO activity in humans, and treatment with antidepressant drugs in rats. If our hypothesis proves to be correct, the longlasting question about the mechanisms underlying the association between trbc MAO activity and personality traits would finally be explained.
Since AP-2␤ has been identified as an important regulator of gene expression during embryonic development of many neural tissues, especially the midbrain, one would assume that if the expression of AP-2␤ itself is altered during certain phases during development, the adult brain would, as a consequence, have an altered biochemical milieu with regard to the monoaminergic systems. The dopamine and serotonin cell bodies are mainly located within the midbrain of an adult brain and are of fundamental importance for personality and a variety of psychiatric disorders (for reviews see Hartmann et al, 76 Cravchik and Goldman 77 ). Central dopamine and serotonin systems are crucial for most brain functions and properties of those systems have been implicated in the constitutional part of personality, 78, 79 as well as in psychiatric disorders, including eating disorders and substance abuse. 60, 80 The AP-2 family, including AP-2␤, has several binding sites in the promoter regions of genes encoding key proteins in the monoamine transmitter systems, [45] [46] [47] [48] [49] [50] [51] [52] [53] and in this way the 'neurochemical individuality' based on 'a genetic diversity among human dopamine and serotonin receptors and transporters' as discussed by Cravshik and Goldman 77 might be explained. Good support for such a view has been given by recent results showing the importance of a functional polymorphism in the serotonin transporter for behavior and early onset alcoholism. 81, 82 In our hypothesis on the connection between trbc MAO and temperament, we have, however, also suggested an even simpler explanation, that eg the number of neurons, preferentially serotonergic, is co-regulated with trbc MAO. 72 This suggestion was based on early findings that there are marked strain-dependent variations in the number of midbrain dopamine neurons in mice 83 and that these variations correlate with interstrain differences in behaviour. 84 Regardless of whether transcriptions factors, such as the AP-2 family, regulate the expression of the number of monoamine neurons or a variety of candidate genes within the monoamine systems, or both, we would like to emphasize the role of transcription factors, besides polymorphisms in monoaminergic candidate genes, when explaining inter-individual differences in temperament and psychiatric vulnerability.
